Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mogamulizumab-associated lymphadenopathy masquerading as lymphoma progression.

JAAD case reports·2026
Same author

Novel <i>NUTM1</i> Fusions in Relapsed Acute Myeloid Leukemia: Expanding the Genetic and Clinical Landscape.

International journal of molecular sciences·2025
Same author

First-in-Human Phase I/IIa Study of the First-in-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

DNA methylation dysregulation patterns in the 1p36 region instability.

Journal of applied genetics·2024
Same author

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

Blood cancer journal·2023
Same author

Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2022
Same journal

Using SNP microarray to distinguish mosaicism from chimerism in a phenotypically normal male newborn with prenatal 46,XX/46,XY karyotype.

Molecular cytogenetics·2026
Same journal

Previously unreported translocation (14;15)(q32; q11.2) observed in B-cell acute lymphoblastic leukemia: a case report.

Molecular cytogenetics·2026
Same journal

Clinical presentation and genotype-phenotype correlation of a novel pure duplication of 6p25.2-p22.3: a case report and literature review.

Molecular cytogenetics·2026
Same journal

Identification of tubulin gene variants in patients with dandy-walker malformation: expanding the spectrum of tubulinopathies.

Molecular cytogenetics·2026
Same journal

Molecular cytogenetics provides insights into heterochromatin composition and karyotypic evolution in species of the Plebeia group (Apidae: Meliponini).

Molecular cytogenetics·2026
Same journal

A fetus with paternal uniparental isodisomy of chromosome 3: genetic analysis and prenatal diagnosis following a positive NIPS with IUGR.

Molecular cytogenetics·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis.

Roger A Schultz1, Maria Delioukina, Karl Gaal

  • 1Signature Genomics, 2820 N, Astor St,, Spokane, WA, 99207, USA. lisa.shaffer@perkinelmer.com.

Molecular Cytogenetics
|February 5, 2011
PubMed
Summary
This summary is machine-generated.

Microarray-based comparative genomic hybridization effectively detects genetic alterations in chronic lymphocytic leukemia (CLL), aiding in understanding disease susceptibility and prognosis. This method identifies copy number imbalances and additional abnormalities, even at low mosaicism levels.

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Related Experiment Videos

Last Updated: Jun 4, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Area of Science:

  • Genomics
  • Cancer Genetics

Background:

  • Chronic lymphocytic leukemia (CLL) exhibits significant clinical variability.
  • Cytogenetic findings are crucial for prognostication and treatment decisions in CLL.

Purpose of the Study:

  • To evaluate the utility of microarray-based comparative genomic hybridization (aCGH) in detecting genetic alterations in CLL.
  • To identify potential genetic factors contributing to CLL susceptibility.

Main Methods:

  • Analysis of 25 clinical CLL cases using a BAC-based aCGH microarray.
  • Comparison of aCGH results with prior cytogenetic and FISH data.

Main Results:

  • aCGH detected copy number imbalances in 15 of 25 CLL cases, consistent with previous studies.
  • Additional genetic abnormalities were identified in 15 cases, including deletions linked to inherited CLL predisposition.
  • aCGH identified aberrations in as little as 10% of cells and detected mosaicism in tetraploid cell populations.

Conclusions:

  • Microarray analysis is a successful method for evaluating CLL genetic landscape.
  • The study identified genetic alterations potentially relevant to CLL susceptibility.